Olaparib - Small Molecule (ID:10144-101)
HMS LINCS ID: | 10144-101 |
Name: | Olaparib |
Alternative Names: | AZD2281; KU-0059436 |
LINCS ID: | LSM-1145 |
PubChem CID: | 23725625 |
ChEBI ID: | |
ChEMBL ID: | |
Molecular Mass: | 434.18 |
InChi: | InChI=1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30) |
InChi Key: | FDLYAMZZIXQODN-UHFFFAOYSA-N |
SMILES: | C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F |
Relevant Citations: | |
Comments: | |
Date Publicly Available: | |
Most Recent Update: | 2016-04-04 |
Target Affinity:
(see Study 20000)Target Affinity Spectrum Value | HUGO Gene Name |
---|---|
PARP1, PARP2 | |
3 (equivalent to 1µM ≤ Kd < 10 µM) | TNKS |
Datasets:
HMS Dataset ID | Dataset Title | HMS Dataset Type |
---|---|---|
20000 | Target Affinity Spectrum (TAS) vectors for compounds in the HMS LINCS small molecule library. | Analysis |
20276 | Protein levels measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with Vemurafenib in combination with chromatin-targeting compounds (immunofluorescence dataset 3 of 4) | Microscopy/Imaging |
20343 | Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values | Microscopy/Imaging |
20344 | Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics | Analysis |
Batch Information:
HMS LINCS Batch ID | Provider | Provider Batch ID |
---|---|---|
10144-101-1 | Haoyuan chemexpress | HM-042_8-20100517 |
10144-101-2 | Haoyuan chemexpress | HM-042_8-20110726 |
10144-101-3 | MedChem Express | 14425 |
(Kd <100 nM)